中(zhong)(zhong)國(guo)醫(yi)藥(yao)(yao)行業正(zheng)經歷創(chuang)(chuang)(chuang)新飛輪效(xiao)應，武(wu)(wu)田制藥(yao)(yao)在華發展成為典(dian)范。武(wu)(wu)田制藥(yao)(yao)通過本(ben)土化(hua)戰(zhan)略(lve)和創(chuang)(chuang)(chuang)新布(bu)局，推(tui)動(dong)了(le)中(zhong)(zhong)國(guo)醫(yi)藥(yao)(yao)產業的發展。2015年起，武(wu)(wu)田加速引進創(chuang)(chuang)(chuang)新產品，并在2018年收購夏爾公司后躋身全(quan)球前十大藥(yao)(yao)企。其"武(wu)(wu)聚未來"計劃明確核心業務領域，并計劃至(zhi)2025年上市(shi)15款創(chuang)(chuang)(chuang)新藥(yao)(yao)，服務超1000萬(wan)患(huan)者。"拓維中(zhong)(zhong)國(guo)"戰(zhan)略(lve)進一步推(tui)動(dong)本(ben)土合(he)作與數字化(hua)創(chuang)(chuang)(chuang)新，使(shi)中(zhong)(zhong)國(guo)成為其全(quan)球第二大市(shi)場目標。(mts)